ObjectiVision takes computerised glaucoma test to the US
This article was originally published in Clinica
Executive Summary
In a move that allows it to expand into the US market, Australian firm ObjectiVision has gained FDA approval to sell a computerised glaucoma test that promises to detect the disease earlier than current methods.